Buy Rating for Mediwound Driven by EscharEx’s Market Potential and Disruptive Role in Chronic Wound Care
Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Mediwound (MDWD – Research Report). The associated price target ...
Buy Rating for Mediwound Driven by EscharEx’s Promising Market Potential and Revenue Growth
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Mediwound (MDWD – Research Report) and keeping the price target ...